Quoin Pharmaceuticals (QNRX) Short Interest Ratio & Short Volume $0.62 -0.01 (-1.59%) (As of 11/21/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Quoin Pharmaceuticals Short Interest DataQuoin Pharmaceuticals (QNRX) has a short interest of 478,400 shares. This marks a 2,391.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 934,176 shares to cover all short positions.Current Short Interest478,400 sharesPrevious Short Interest19,200 sharesChange Vs. Previous Month+2,391.67%Dollar Volume Sold Short$357,412.64Short Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares5,050,000 sharesPercentage of Shares Shorted9.47%Today's Trading Volume46,783 sharesAverage Trading Volume934,176 sharesToday's Volume Vs. Average5% Short Selling Quoin Pharmaceuticals? Sign up to receive the latest short interest report for Quoin Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartQNRX Short Interest Over TimeQNRX Days to Cover Over TimeQNRX Percentage of Float Shorted Over Time Ad WealthPressThe Tesla Trade Is Back In BusinessIf you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.Discover how to trade Tesla, simply follow this link here. Quoin Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024478,400 shares $357,412.64 +2,391.7%N/A0.2 $0.75 10/15/202419,200 shares $9,676.80 +26.3%N/A0 $0.50 9/30/202415,200 shares $7,493.60 -92.1%N/A0 $0.49 9/15/2024193,500 shares $116,351.55 +1,473.2%N/A0.4 $0.60 8/31/202412,300 shares $7,701.03 +373.1%N/A0 $0.63 8/15/20242,600 shares $1,299.74 -80.5%N/A0.1 $0.50 Get the Latest News and Ratings for QNRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quoin Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202413,300 shares $7,985.32 +118.0%N/A0.3 $0.60 7/15/20246,100 shares $3,990.01 -52.7%N/A0.1 $0.65 6/30/202412,900 shares $7,482.00 +148.1%N/A0.2 $0.58 6/15/20245,200 shares $3,568.24 -56.3%N/A0.1 $0.69 5/31/202411,900 shares $9,247.49 +325.0%N/A0.1 $0.78 5/15/20242,800 shares $2,172.80 -70.5%N/A0 $0.78 4/30/20249,500 shares $6,726.00 -37.9%N/A0 $0.71 4/15/202415,300 shares $11,245.50 +31.9%N/A0 $0.74 3/31/202411,600 shares $11,020.00 -65.6%N/A0 $0.95 3/15/202433,700 shares $32,250.90 +159.2%N/A0.1 $0.96 2/29/202413,000 shares $35,815.00 +381.5%N/A0 $2.76 2/15/20242,700 shares $7,533.00 +8.0%N/A0.1 $2.79 1/31/20242,500 shares $8,925.00 +212.5%N/A0.1 $3.57 1/15/2024800 shares $3,552.00 -87.3%N/A0 $4.44 12/31/20236,300 shares $30,901.50 -78.6%N/A0.2 $4.91 12/15/202329,400 shares $127,596.00 +2,840.0%N/A0.9 $4.34 11/30/20231,000 shares $4,973.10 -85.7%N/A0.1 $4.97 11/15/20237,000 shares $29,750.00 +133.3%N/A0.4 $4.25 10/31/20233,000 shares $12,210.00 -30.2%N/A0.1 $4.07 10/15/20234,300 shares $16,985.00 +87.0%N/A0.1 $3.95 9/30/20232,300 shares $9,545.00 -30.3%N/A0 $4.15 9/15/20233,300 shares $18,183.00 -64.5%N/A0 $5.51 8/31/20239,300 shares $53,475.00 -30.6%N/A0.1 $5.75 8/15/202313,400 shares $71,824.00 -76.2%N/A0.1 $5.36 7/31/202356,200 shares $442,294.00 +524.4%N/A0.4 $7.87 7/15/20239,000 shares $60,480.00 -94.0%N/A0.1 $6.72 6/30/2023149,400 shares $74,746.61 +76.8%N/A0.6 $0.50 6/15/202384,500 shares $45,630.00 +0.7%N/A0.3 $0.54 5/31/202383,900 shares $35,699.45 +156.6%N/A0.3 $0.43 5/15/202332,700 shares $15,924.90 -84.1%N/A0.1 $0.49 4/30/2023205,500 shares $102,750.00 +448.0%N/A0.4 $0.50 4/15/202337,500 shares $19,031.25 -29.1%N/A0.1 $0.51 3/31/202352,900 shares $25,159.24 -62.3%N/A0.1 $0.48 3/15/2023140,400 shares $71,491.68 +61.6%N/A0.2 $0.51Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. 2/28/202386,900 shares $49,498.24 -73.6%N/A0.1 $0.57 2/15/2023328,900 shares $509,795.00 +1,118.2%N/A0.6 $1.55 1/31/202327,000 shares $45,090.00 +52.5%N/A0.1 $1.67 1/15/202317,700 shares $29,382.00 +46.3%N/A0.1 $1.66 12/30/202212,100 shares $17,182.00 +27.4%N/A0 $1.42 12/15/20229,500 shares $14,535.00 -33.6%N/A0 $1.53 11/30/202214,300 shares $23,881.00 -74.8%N/A0 $1.67 11/15/202256,700 shares $108,297.00 -33.7%N/A0 $1.91 10/31/202285,500 shares $158,175.00 +152.2%N/A0.1 $1.85 10/15/202233,900 shares $57,969.00 -1.5%N/A0 $1.71 9/30/202234,400 shares $76,712.00 -85.6%N/A0 $2.23 9/15/2022238,800 shares $940,872.00 +423.7%N/A0.1 $3.94 8/31/202245,600 shares $149,112.00 -71.9%N/A0 $3.27 8/15/2022162,000 shares $764,640.00 +116.9%N/A0.1 $4.72 7/31/202274,700 shares $333,068.63 -92.4%N/A0.1 $4.46 7/15/2022986,500 shares $404,465.00 +19.1%N/A0.3 $0.41 6/30/2022828,300 shares $372,735.00 +162.8%N/A0.3 $0.45 6/15/2022315,200 shares $124,188.80 +923.4%N/A0.2 $0.39 5/31/202230,800 shares $19,558.00 -34.2%N/A0 $0.64 5/15/202246,800 shares $29,165.76 -83.5%N/A0.1 $0.62 4/30/2022284,200 shares $227,644.20 +120.7%N/A0.4 $0.80 4/15/2022128,800 shares $157,136.00 -14.1%N/A0.2 $1.22 3/31/2022150,000 shares $199,500.00 -33.9%N/A0.1 $1.33 3/15/2022226,900 shares $283,625.00 +94.8%N/A0.1 $1.25 2/28/2022116,500 shares $129,315.00 -45.9%N/A0.1 $1.11 2/15/2022215,300 shares $305,726.00 +192.5%N/A0.1 $1.42 1/31/202273,600 shares $102,304.00 -59.5%N/A0 $1.39 1/15/2022181,500 shares $294,030.00 -6.0%N/A0.1 $1.62 12/31/2021193,100 shares $351,442.00 No ChangeN/A0.1 $1.82 QNRX Short Interest - Frequently Asked Questions What is Quoin Pharmaceuticals' current short interest? Short interest is the volume of Quoin Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 478,400 shares of QNRX short. Learn More on Quoin Pharmaceuticals' current short interest. Is Quoin Pharmaceuticals' short interest increasing or decreasing? Quoin Pharmaceuticals saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 478,400 shares, an increase of 2,391.7% from the previous total of 19,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Quoin Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "medical equipment" compare to Quoin Pharmaceuticals: QT Imaging Holdings, Inc. (1.04%), Lyra Therapeutics, Inc. (3.12%), PAVmed Inc. (3.25%), Innovative Eyewear, Inc. (71.78%), SeaStar Medical Holding Co. (7.22%), T2 Biosystems, Inc. (14.44%), Star Equity Holdings, Inc. (1.47%), NeuroMetrix, Inc. (1.08%), Pixie Dust Technologies, Inc. (1.35%), Plus Therapeutics, Inc. (0.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Quoin Pharmaceuticals stock? Short selling QNRX is an investing strategy that aims to generate trading profit from Quoin Pharmaceuticals as its price is falling. QNRX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Quoin Pharmaceuticals? A short squeeze for Quoin Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of QNRX, which in turn drives the price of the stock up even further. How often is Quoin Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QNRX, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Lyra Therapeutics Short Squeeze PAVmed Short Squeeze QT Imaging Short Squeeze Innovative Eyewear Short Squeeze SeaStar Medical Short Squeeze Star Equity Short Squeeze T2 Biosystems Short Squeeze Pixie Dust Technologies Short Squeeze NeuroMetrix Short Squeeze Intelligent Bio Solutions Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QNRX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quoin Pharmaceuticals, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quoin Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.